COMP <GO>
INVX vs AMZN // FREE CASH FLOW YIELD
Innovex International Inc. (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: INVX 5
— AMZN 3
▲ FREE CASH FLOW YIELD LEADER: INVX
LAST: $30.00 (-1.22%) • MKT CAP: $2.10B
fcf-yield
9.10%
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
fcf-yield
-1.81%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INVX VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INVX | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 17.61% | -7.71 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 15.8x | +0.05 | AMZN | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 9.10% | -1.81% | +10.91 | INVX | /fcf-yield <GO> |
| Operating Margin | 13.60% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 8.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 48.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.96 | 3.32 | +4.64 | INVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | INVX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 47.2 | +7.40 | INVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.2x | 21.7x | -0.48 | INVX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.10B | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INVX REV | AMZN REV | INVX GROSS % | AMZN GROSS % | INVX FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $978.3M | $0 | 31.0% | — | $190.9M | $10.56B |
| FY 2024 | $660.8M | $0 | 35.2% | — | $93.4M | $42.95B |
| FY 2023 | $555.5M | $0 | — | — | $75.9M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INVX // BETA —
AMZN // BETA 1.46